Hyphens Pharma International Ltd
SGX:1J5
Net Margin
Hyphens Pharma International Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| SG |
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
91.1m SGD |
5%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
708B USD |
23%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
369.6B USD |
24%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK |
35%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
209.5B CHF |
14%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
182.8B CHF |
24%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
161.5B GBP |
14%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
196.2B USD |
27%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
-126%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
133.7B USD |
13%
|
Hyphens Pharma International Ltd
Glance View
Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Hyphens Pharma International Ltd's most recent financial statements, the company has Net Margin of 5.2%.
You don't have any saved screeners yet